|
Bethanechol Chloride Oral Solution
» Bethanechol Chloride Oral Solution contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of bethanechol chloride (C7H17ClN2O2). Prepare Bethanechol Chloride Oral Solution 5 mg per mL as follows (see Pharmaceutical CompoundingNonsterile Preparations
Add Bethanechol Chloride powder and about 20 mL of Vehicle to a mortar, and mix. Add the Vehicle in small portions almost to volume, and mix thoroughly after each addition. Transfer the contents of the mortar, stepwise and quantitatively, to a calibrated bottle. Add enough Vehicle to bring to final volume, and mix well.
Packaging and storage
Preserve in tight, light-resistant containers. Store at room temperature or in a cold place.
Labeling
Label it to state the beyond-use date.
pH
Beyond-use date:
60 days after the day on which it was compounded.
Assay
Mobile phase
Prepare a filtered and degassed solution of water and acetonitrile (67:33). Make adjustments if necessary (see System Suitability under Chromatography
Standard preparation
Dissolve an accurately weighed quantity of USP Bethanechol Chloride RS in Mobile phase, and dilute quantitatively with Mobile phase to obtain a solution having a known concentration of about 500 µg per mL.
Assay preparation
Agitate the container of Oral Solution for 30 minutes on a rotating mixer, remove a 10-mL sample, and store in a clear glass vial at 70
Chromatographic system (see Chromatography
Procedure
Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of bethanechol chloride (C7H17ClN2O2) in the volume of Oral Solution taken by the formula:
10(C / V)(rU / rS)
in which C is the concentration, in µg per mL, of USP Bethanechol Chloride RS in the Standard preparation; V is the volume, in mL, of Oral Solution taken; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP32NF27 Page 1671
Pharmacopeial Forum: Volume No. 32(1) Page 55
|